台北醫學院 醫學系 學士 1984.10~1991.06

和信治癌中心醫院 一般外科 碩學主治醫師 2011.01~迄今
部定講師2007.02~迄今
和信治癌中心醫院 外科部 主任 2011.10~2021.09
和信治癌中心醫院 一般外科 資深主治醫師 2005.01~2010.12
和信治癌中心醫院 一般外科 主治醫師 1998.08~2004.12
美國杜克大學 Surgical Oncology Fellow 2002.07~2003.06
臺北榮民總醫院 一般外科 住院總醫師 1997.06~1998.06
臺北榮民總醫院 一般外科 住院醫師 1993.06~1997.06

台灣外科醫學會/外科專科醫師
台灣消化系外科醫學會/消化系外科專科醫師
台灣乳房醫學會/中華民國乳房外科專科醫師
台灣內分泌外科醫學會/台灣內分泌外科醫學會專科醫師
台灣靜脈暨腸道營養醫學/營養醫療專科醫師
中華民國癌症醫學會/腫瘤外科專科醫師訓練指導醫師
台灣機器人手術醫學會/達文西機械手臂輔助消化系外科醫師資格
台北市醫師公會

1. Cheng TY, Su CH, Shyr YM, Lui WY. Management of pancreatic lesions in von Hippel-Lindau disease. World J Surg 1997; 21:307-312.
2. Abdel-Wahab Z, Kalady MF, Emani S, Onaitis MW, Abdel-Wahab OI, Cisco R, Wheless L, Cheng TY, Tyler DS, Pruitt SK. Induction of anti-melanoma CTL response using DC transfected with mutated mRNA encoding full-length Melan-A/MART-1 antigen with an A27L amino acid substitution. Cell Immunol 2003; 224:86-97.
3. Cheng TY, Grubbs E, Abdul-Wahab O, Leu SY, Hung CF, Petros W, Aloia T, Fedrau R, Pruitt S, Colvin M, Friedman H, Tyler D. Marked variability of melphalan plasma drug levels during regional hyperthermic isolated limb perfusion. Am J Surg 2003; 186:460-467.
4. Grubbs EG, Abdel-Wahab O, Cheng TY, Abdel-Wahab Z, Peterson B, Pruitt SK, Colvin OM, Friedman HS, Tyler DS. In-transit melanoma: The role of alkylating-agent resistance in regional therapy. J Am Coll Surg 2004; 199:419-427.
5. Grubbs EG, Ueno T, Abdel-Wahab O, Cheng TY, Pruitt SK, Michael Colvin O, Friedman HS, Tyler DS. Modulation of resistance to regional chemotherapy in the extremity melanoma model. Surgery 2004; 136:210-218.
6. Huang Y, Tsung JS, Lin CW, Cheng TY. Intrahepatic cholangiocarcinoma with lymphoepithelioma-like carcinoma component. Ann Clin Lab Sci 2004; 34:476-480.
7. Abdel-Wahab OI, Grubbs E, Viglianti BL, Cheng TY, Ueno T, Ko S, Rabbani Z, Curtis S, Pruitt SK, Dewhirst MW, Tyler DS. The role of hyperthermia in regional alkylating agent chemotherapy. Clin Cancer Res 2004; 10:5919-5929.
8. Aloia TA, Grubbs E, Onaitis M, Mosca PJ, Cheng TY, Seigler H, Tyler DS. Predictors of outcome after hyperthermic isolated limb perfusion: role of tumor response. Arch Surg 2005; 140:1115-1120.
9. Shih NN, Tsung JS, Yang AH, Tsou MH, Cheng TY. A unique pancreatic tumor with exclusive hepatocytic differentiation. Ann Clin Lab Sci 2006; 36:216-221.
10. Ueno T, Ko SH, Grubbs E, Yoshimoto Y, Augustine C, Abdel-Wahab Z, Cheng TY, Abdel-Wahab OI, Pruitt SK, Friedman HS, Tyler DS. Modulation of chemotherapy resistance in regional therapy: a novel therapeutic approach to advanced extremity melanoma using intra-arterial temozolomide in combination with systemic O⁶-benzylguanine. Mol Cancer Ther 2006; 5:732-738.
11. Cheng TY, Sheth K, White RR, Ueno T, Hung CF, Clary BM, Pappas TN, Tyler DS. Effect of neoadjuvant chemoradiation on operative mortality and morbidity for pancreaticoduodenectomy. Ann Surg Oncol 2006; 13:66-74.
12. Beasley GM, Petersen RP, Yoo J, McMahon N, Aloia T, Petros W, Sanders G, Cheng TY, Pruitt SK, Seigler H, Tyler DS.  Isolated limb infusion for in-transit malignant melanoma of the extremity: a well-tolerated but less effective alternative to hyperthermic isolated limb perfusion. Ann Surg Oncol 2008; 15:2195-2205.
13. McMahon N, Cheng TY, Beasley GM, Spasojevic I, Petros W, Augustine CK, Zipfel P, Padussis JC, Sanders G, Tyler DS.  Optimizing melphalan pharmacokinetics in regional melanoma therapy: does correcting for ideal body weight alter regional response or toxicity? Ann Surg Oncol 2009; 16:953-961.
14. Cheng TY, Chen CM, Lee MY, Lin KJ, Hung CF, Yang PS, Yu BL, Yang CE, Tsai  TJ, Lin CW.  Risk Factors Associated with Conversion from Nonmalignant to Malignant Diagnosis After Surgical Excision of Breast Papillary Lesions. Ann Surg Oncol 2009, 16:3375-3379.
15. Shih-Hsuan Wu, Ben-Long Yu, Chii-Ming Chen, Chen-En Yang, Tzu-Jung Tsai, Chung-Wei Lin, Tsung-Yen Cheng, Dong-Ling You, Yu-Yi Huang, Pei-Ing Lee, Mei-Hua Tsou, Ming-Yuan Lee, Ai-Ying Chuang, Wen-Hui Ku, Christopher K.J. Lin, Woan-Chwen Jaw, Wan-Chen Tsai, Po-Sheng Yang.  Experience with Sentinel Lymph Node Biopsy in Early Breast Cancer Patients at a Cancer Center. J. Cancer Res. Pract. 26(1), 21-27, 2010
16. Wang YH, Cheng TY, Chen TY, Chang KM, Chuang VP, Kao KJ. Plasmalemmal Vesicle Associated Protein (PLVAP) as a therapeutic target for treatment of hepatocellular carcinoma. BMC Cancer. 2014;14:815.
17. Chia-Yuan Chang, Tsung-Yen Cheng, Chen-Fang Hung, Ben-Long Yu, Tzu-Jung Tsai, Chung-Wei Lin.  Gallstone formation after gastrectomy for adenocarcinoma of the stomach. Formosan Journal of Surgery (2015)48, 198-202.
18. Chung-Wei Lin, Tzu-Jung Tsai, Tsung-Yen Cheng, Hung-Kuang Wei, Chen-Fang Hung, Yin-Yin Chen, Chii-Ming Chen.  The learning curve of laparoscopic liver resection after the Louisville statement 2008: Will it be more effective and smooth? Surgical Endoscopy 2015